QQQ   303.59 (-0.85%)
AAPL   151.73 (-1.79%)
MSFT   256.77 (-0.61%)
META   186.06 (-0.25%)
GOOGL   102.90 (-1.79%)
AMZN   102.18 (-1.17%)
TSLA   194.76 (+2.52%)
NVDA   210.89 (-0.05%)
NIO   10.93 (-2.32%)
BABA   105.45 (-0.83%)
AMD   83.68 (-2.80%)
T   19.58 (-1.26%)
F   13.14 (-0.68%)
MU   59.98 (-3.89%)
CGC   2.95 (+1.03%)
GE   82.35 (+0.48%)
DIS   109.87 (-0.76%)
AMC   6.80 (+11.84%)
PFE   43.76 (-0.68%)
PYPL   82.33 (-3.73%)
NFLX   361.48 (-1.21%)
QQQ   303.59 (-0.85%)
AAPL   151.73 (-1.79%)
MSFT   256.77 (-0.61%)
META   186.06 (-0.25%)
GOOGL   102.90 (-1.79%)
AMZN   102.18 (-1.17%)
TSLA   194.76 (+2.52%)
NVDA   210.89 (-0.05%)
NIO   10.93 (-2.32%)
BABA   105.45 (-0.83%)
AMD   83.68 (-2.80%)
T   19.58 (-1.26%)
F   13.14 (-0.68%)
MU   59.98 (-3.89%)
CGC   2.95 (+1.03%)
GE   82.35 (+0.48%)
DIS   109.87 (-0.76%)
AMC   6.80 (+11.84%)
PFE   43.76 (-0.68%)
PYPL   82.33 (-3.73%)
NFLX   361.48 (-1.21%)
QQQ   303.59 (-0.85%)
AAPL   151.73 (-1.79%)
MSFT   256.77 (-0.61%)
META   186.06 (-0.25%)
GOOGL   102.90 (-1.79%)
AMZN   102.18 (-1.17%)
TSLA   194.76 (+2.52%)
NVDA   210.89 (-0.05%)
NIO   10.93 (-2.32%)
BABA   105.45 (-0.83%)
AMD   83.68 (-2.80%)
T   19.58 (-1.26%)
F   13.14 (-0.68%)
MU   59.98 (-3.89%)
CGC   2.95 (+1.03%)
GE   82.35 (+0.48%)
DIS   109.87 (-0.76%)
AMC   6.80 (+11.84%)
PFE   43.76 (-0.68%)
PYPL   82.33 (-3.73%)
NFLX   361.48 (-1.21%)
QQQ   303.59 (-0.85%)
AAPL   151.73 (-1.79%)
MSFT   256.77 (-0.61%)
META   186.06 (-0.25%)
GOOGL   102.90 (-1.79%)
AMZN   102.18 (-1.17%)
TSLA   194.76 (+2.52%)
NVDA   210.89 (-0.05%)
NIO   10.93 (-2.32%)
BABA   105.45 (-0.83%)
AMD   83.68 (-2.80%)
T   19.58 (-1.26%)
F   13.14 (-0.68%)
MU   59.98 (-3.89%)
CGC   2.95 (+1.03%)
GE   82.35 (+0.48%)
DIS   109.87 (-0.76%)
AMC   6.80 (+11.84%)
PFE   43.76 (-0.68%)
PYPL   82.33 (-3.73%)
NFLX   361.48 (-1.21%)
CVE:ADK

DIAGNOS - ADK Stock Forecast, Price & News

C$0.38
+0.04 (+10.14%)
(As of 02/6/2023 05:20 PM ET)
Add
Compare
Today's Range
C$0.35
C$0.38
50-Day Range
C$0.18
C$0.39
52-Week Range
C$0.13
C$0.43
Volume
76,200 shs
Average Volume
153,368 shs
Market Capitalization
C$26.40 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
ADK stock logo

About DIAGNOS (CVE:ADK) Stock

DIAGNOS Inc. provides software-based services primarily in Canada, the United States, Colombia, Spain, Mexico, Saudi Arabia, and Costa Rica. The company offers healthcare services through Computer Assisted Retina Analysis, a web-based software tool that assists healthcare professionals for the detection of diabetic retinopathy; and allows eye care specialist to visualize both normal retinal landmarks and pathological changes. It also provides various consulting services in the fields of data analysis and artificial intelligence. The company was founded in 1998 and is headquartered in Brossard, Canada.

Receive ADK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for DIAGNOS and its competitors with MarketBeat's FREE daily newsletter.

ADK Stock News Headlines

Profit From the Commercial Solar Boom?
Solar energy had its best year ever in 2021, with a record 24 gigawatts of power installed. That's enough to power 18 million homes! Analysts expect the global solar farm market to reach $356 billion by 2028. The utility segment of the solar market is expected to grow at the highest annual growth rate in the industry, especially with the many tax incentives now offered.
DIAGNOS Successfully Completes ISO / MDSAP Audit
A gold storm is coming…
“We are in the early stages of a mania – the calm before the storm.”...
DIAGNOS Announces Stock Options Grants
DIAGNOS Announces Exercise of Stock Warrants and Provides a Cash Update
Health-Care Stocks on the March
Diagnos Inc.
DIAGNOS Inc/Canada
DIAGNOS Announces Stock Options Grant
See More Headlines
Receive ADK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for DIAGNOS and its competitors with MarketBeat's FREE daily newsletter.

ADK Company Calendar

Last Earnings
11/29/2022
Today
2/06/2023
Next Earnings (Estimated)
7/12/2023

Industry, Sector and Symbol

Industry
Health Information Services
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$577,486.00
Cash Flow
C$0.01 per share
Book Value
C($0.02) per share

Miscellaneous

Free Float
N/A
Market Cap
C$26.40 million
Optionable
Not Optionable
Beta
N/A

Key Executives

  • Mr. Andre Larente
    CEO, Pres & Exec. Director
  • Mr. Marc-André Massue
    VP of Fin., CFO & Sec.
  • Mr. Guillermo Moreno Robles
    VP of Sales
  • Mr. Martin Beland
    Director of Marketing













ADK Stock - Frequently Asked Questions

How have ADK shares performed in 2023?

DIAGNOS's stock was trading at C$0.28 on January 1st, 2023. Since then, ADK shares have increased by 35.7% and is now trading at C$0.38.
View the best growth stocks for 2023 here
.

When is DIAGNOS's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, July 12th 2023.
View our ADK earnings forecast
.

How were DIAGNOS's earnings last quarter?

DIAGNOS Inc. (CVE:ADK) released its earnings results on Tuesday, November, 29th. The company reported ($0.01) earnings per share (EPS) for the quarter. The business earned $0.15 million during the quarter, compared to the consensus estimate of $0.30 million.

What other stocks do shareholders of DIAGNOS own?

Based on aggregate information from My MarketBeat watchlists, some companies that other DIAGNOS investors own include Marijuana Company of America (MCOA), Maxar Technologies (MAXR) and Main Street Capital (MAIN).

What is DIAGNOS's stock symbol?

DIAGNOS trades on the Canadian Venture Exchange (CVE) under the ticker symbol "ADK."

How do I buy shares of DIAGNOS?

Shares of ADK stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What is DIAGNOS's stock price today?

One share of ADK stock can currently be purchased for approximately C$0.38.

How much money does DIAGNOS make?

DIAGNOS (CVE:ADK) has a market capitalization of C$26.40 million and generates C$577,486.00 in revenue each year.

How can I contact DIAGNOS?

DIAGNOS's mailing address is 7005 Taschereau Blvd, Suite 340 Brossard, BROSSARD, QC J4Z 1A7, Canada. The official website for the company is www.diagnos.ca. The company can be reached via phone at +1-450-6788882.

This page (CVE:ADK) was last updated on 2/6/2023 by MarketBeat.com Staff